Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $80.00 USD
Change Today +1.84 / 2.35%
Volume 468.5K
PCRX On Other Exchanges
Symbol
Exchange
NASDAQ GS
As of 2:09 PM 05/28/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Gary Patou M.D.

Chief Medical Officer, Pacira Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 7 board members in 1 different organizations across 5 different industries.

See Board Relationships
55$1,885,043
As of Fiscal Year 2014

Background*

Dr. Gary Patou, M.D. has been Senior Medical Advisor at Chiasma (Israel) ltd. since 2014. Dr. Patou serves as the Managing Director of MPM Capital since May 2005. Dr. Patou joined MPM Capital in 2005. He has been the Chief Medical Officer Pacira Pharmaceuticals, Inc. since March 2009. He served as Consultant at Peplin, Inc. since June 2008 until June 30, 2009. He served as the Interim Chief Medical Officer of Peplin, Ltd. from June 2008 to April 2008 and its interim ...

Read Full Background

Corporate Headquarters*

5 Sylvan Way
Parsippany, New Jersey 07054

United States

Phone: 973-254-3560
Fax: --

Board Members Memberships*

2004-Present
Independent Director, Chairman of Nominating & Corporate Governance Committee and Member of Compensation Committee
2005-2008
Former Director and Chairman of Compliance Committee

Education*

PhD
University College London
Bachelor's Degree
University College London
BS
University College London
MD
University College London

Other Affiliations*

Annual Compensation*

Salary$317,600
Bonus$90,000
Total Annual Compensation$407,600

Stock Options*

Exercised Options80,000
Exercised Options Value$6,334,748
Exercisable Options42,960
Exercisable Options Value$3,349,674
Unexercisable Options62,443
Unexercisable Options Value$3,086,907
Total Value of Options$12,771,329
Total Number of Options185,403

Total Compensation*

Total Annual Cash Compensation$407,600
Total Short Term Compensation$407,600
Total Calculated Compensation$1,885,043
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PCRX:US $80.00 USD +1.84

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Richard F. Pops Chairman of the Board and Chief Executive Officer
Alkermes plc
$854.7K
James E. Brown D.V.M.Co-Founder, Chief Executive Officer, President and Director
DURECT Corporation
$470.4K
Rajat Rai Chief Executive Officer
Akorn, Inc.
$1.1M
A. J. Kazimi MBAFounder, Chairman, Chief Executive Officer and President
Cumberland Pharmaceuticals, Inc.
$650.0K
Robert E. Abernathy Chairman, Chief Executive Officer, President and Member of Executive Committee
Halyard Health, Inc.
$787.5K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PACIRA PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.